TGFB1 and Hepatic fibrosis: Furthermore, VSC-CDs demonstrated the ability to modulate the TGF-β/Smad signaling pathway and regulate the protein expressions of α-SMA and COI1, thereby inhibiting the progression of liver fibrosis.